154 related articles for article (PubMed ID: 26793892)
1. [Drastic changes in the treatment of metastatic prostate cancer].
Thellenberg Karlsson C; Ståhl O
Lakartidningen; 2024 Apr; 121():. PubMed ID: 38651316
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective.
Namiki M; Ueno S; Kitagawa Y; Fukagai T; Akaza H
Asian J Androl; 2012 May; 14(3):451-7. PubMed ID: 22447200
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Gillessen S; Omlin A; Attard G; de Bono JS; Efstathiou E; Fizazi K; Halabi S; Nelson PS; Sartor O; Smith MR; Soule HR; Akaza H; Beer TM; Beltran H; Chinnaiyan AM; Daugaard G; Davis ID; De Santis M; Drake CG; Eeles RA; Fanti S; Gleave ME; Heidenreich A; Hussain M; James ND; Lecouvet FE; Logothetis CJ; Mastris K; Nilsson S; Oh WK; Olmos D; Padhani AR; Parker C; Rubin MA; Schalken JA; Scher HI; Sella A; Shore ND; Small EJ; Sternberg CN; Suzuki H; Sweeney CJ; Tannock IF; Tombal B
Ann Oncol; 2015 Aug; 26(8):1589-604. PubMed ID: 26041764
[TBL] [Abstract][Full Text] [Related]
4. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target.
Chen Y; Clegg NJ; Scher HI
Lancet Oncol; 2009 Oct; 10(10):981-91. PubMed ID: 19796750
[TBL] [Abstract][Full Text] [Related]
5. Evolution of hormonal therapy for prostate cancer.
Homewood D; Fu MH; Sathianathen N; La Bianca S; Tran B; Corcoran NM
Aust J Gen Pract; 2024 May; 53(5):291-300. PubMed ID: 38697060
[TBL] [Abstract][Full Text] [Related]
6. RE: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.
Briganti A; Gandaglia G; Fossati N; Moschini M; Montorsi F
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26209710
[No Abstract] [Full Text] [Related]
7. Effect of hormonal therapies for prostate cancer on cognition: The ongoing search for clarity.
Lim Fat G; Alibhai S
Cancer; 2024 Jun; 130(12):2098-2100. PubMed ID: 38491974
[No Abstract] [Full Text] [Related]
8. Glucocorticoids and prostate cancer treatment: friend or foe?
Montgomery B; Cheng HH; Drechsler J; Mostaghel EA
Asian J Androl; 2014; 16(3):354-8. PubMed ID: 24625881
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies in castrate-resistant prostate cancer.
Zarour L; Alumkal J
Curr Urol Rep; 2010 May; 11(3):152-8. PubMed ID: 20425621
[TBL] [Abstract][Full Text] [Related]
10. Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions.
Kvízová J; Pavlíčková V; Kmoníčková E; Ruml T; Rimpelová S
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921501
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy in the management of prostate cancer: evidence-based approaches.
Gomella LG; Singh J; Lallas C; Trabulsi EJ
Ther Adv Urol; 2010 Aug; 2(4):171-81. PubMed ID: 21789093
[TBL] [Abstract][Full Text] [Related]
12. Role of hormonal therapy for prostate cancer: perspective from Japanese experiences.
Namiki M; Ueno S; Kitagawa Y
Transl Androl Urol; 2012 Sep; 1(3):160-72. PubMed ID: 26813083
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers.
Chahoud J; Anderson ARA; Zhang J; Brown J; Gatenby RA
J Clin Oncol; 2023 Oct; 41(28):4469-4471. PubMed ID: 37418680
[TBL] [Abstract][Full Text] [Related]
14. [Hormonal therapy for advanced prostate cancer: current status and issues].
Akakura K
Nihon Rinsho; 2016 Jan; 74(1):124-8. PubMed ID: 26793892
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
[TBL] [Abstract][Full Text] [Related]
16. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
17. [Hormone therapy of locally advanced and metastatic prostate carcinoma].
Rübben H
Praxis (Bern 1994); 2001 Sep; 90(38):1641-4. PubMed ID: 11675917
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in hormonal therapy for advanced prostate cancer.
Oottamasathien S; Crawford ED
Oncology (Williston Park); 2003 Aug; 17(8):1047-52; discussion 1054-8. PubMed ID: 12966672
[TBL] [Abstract][Full Text] [Related]
19. Combined androgen blockade: the gold standard for metastatic prostate cancer.
McLeod DG; Crawford ED; DeAntoni EP
Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
